U.S., Oct. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07892976) titled 'The CORE Platform Trial' on Oct. 19.
Brief Summary: Background: The leading cause of death worldwide is cardiovascular disease, with an estimated 19.8 million deaths per year. Coronary artery disease is a type of cardiovascular disease that can be treated with revascularisation interventions like coronary artery bypass grafting (CABG), percutaneous coronary intervention (PCI) and hybrid revascularisation (CABG and PCI). The COronary Revascularisation (CORE) Platform Trial is a multicentre, investigator-initiated, platform trial designed to evaluate several procedural and medical interventions for treatment of patients with coronary ...